<p><b>Legend:</b> CGIC: Clinical Global Impression of Change.</p><p>SAPS: Scale for Assessment of Positive Symptoms.</p><p>BPRS: Brief Psychiatric Rating Scale.</p><p>PANSS: Positive and Negative Syndrome Scale.</p
The variable results of positive-negative research with schizo-phrenics underscore the importance of...
n the last 25 years, the Positive and Negative Syndrome Scale (PANSS) has been largely used to asses...
Although the Positive and Negative Syndrome Scale (PANSS) was developed for use in schizophrenia (SZ...
Objective: This pilot, twelve-week, open-label study examined the effect of clozapine orally disinte...
Objectives: In recent years schizophrenia trials suffer from diminishing differences in effects of d...
Lack of hard clinical endpoints is an essential problem in schizophrenia research. Disease state and...
The majority of clinical drug trials only cover a small number of variables over a short period of t...
<p>IQR: interquartile range.</p><p>CED: chlorpromazine equivalent dose.</p><p>MRS: Modified Roger's ...
Clozapine is the most effective antipsychotic for the 25% to 33% of people with schizophrenia who ar...
<p>Scores on evaluation scales are mean values (standard deviation).</p><p>Student's <i>t</i>-test.<...
Background: Linking of the Clinical Global Impression (CGI) Scale and the Positive and Negative Synd...
Aim. The aim of the study was to evaluate the degree of statistic correlation of some of the best kn...
Background: The subjective experience of patients with schizophrenia, receiving antipsychotic medica...
OBJECTIVE: The 30-item Positive and Negative Syndrome Scale (PANSS-30) is the most widely used ratin...
The purpose of this study was to develop the Glasgow Antipsychotic Side effects Scale for Clozapine ...
The variable results of positive-negative research with schizo-phrenics underscore the importance of...
n the last 25 years, the Positive and Negative Syndrome Scale (PANSS) has been largely used to asses...
Although the Positive and Negative Syndrome Scale (PANSS) was developed for use in schizophrenia (SZ...
Objective: This pilot, twelve-week, open-label study examined the effect of clozapine orally disinte...
Objectives: In recent years schizophrenia trials suffer from diminishing differences in effects of d...
Lack of hard clinical endpoints is an essential problem in schizophrenia research. Disease state and...
The majority of clinical drug trials only cover a small number of variables over a short period of t...
<p>IQR: interquartile range.</p><p>CED: chlorpromazine equivalent dose.</p><p>MRS: Modified Roger's ...
Clozapine is the most effective antipsychotic for the 25% to 33% of people with schizophrenia who ar...
<p>Scores on evaluation scales are mean values (standard deviation).</p><p>Student's <i>t</i>-test.<...
Background: Linking of the Clinical Global Impression (CGI) Scale and the Positive and Negative Synd...
Aim. The aim of the study was to evaluate the degree of statistic correlation of some of the best kn...
Background: The subjective experience of patients with schizophrenia, receiving antipsychotic medica...
OBJECTIVE: The 30-item Positive and Negative Syndrome Scale (PANSS-30) is the most widely used ratin...
The purpose of this study was to develop the Glasgow Antipsychotic Side effects Scale for Clozapine ...
The variable results of positive-negative research with schizo-phrenics underscore the importance of...
n the last 25 years, the Positive and Negative Syndrome Scale (PANSS) has been largely used to asses...
Although the Positive and Negative Syndrome Scale (PANSS) was developed for use in schizophrenia (SZ...